The SURMOUNT-2 trial , which included participants with type 2 diabetes, similarly demonstrated significant reductions in body weight (average 15.7% with 15 mg dose) and waist circumference
Finally, Section 396 of the FDCA expressly authorizes off-label use: Nothing in this chapter shall be construed to limit or interfere with the authority of a health care practitioner to prescribe or administer any legally marketed device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship. Because physicians lawfully may prescribe off-label, there also is no question that pharmacies lawfully may fill the orders they receive
Learn If You Qualify Cellular Longevity Supports telomere health and cellular replication capacity, potentially slowing cellular aging and promoting healthy tissue function across organ systems
Gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) are most common during dose escalation
Trial-Ready Preparation From the Start Cases are prepared as if they will be tried, even when resolution occurs earlier
In large trials, patients lost an average of 15%21% of their body weight over time, even without intensive lifestyle changes
&srotate=0)
